Invention Grant
- Patent Title: Dihydropyrrolopyridine inhibitors of ROR-gamma
- Patent Title (中): ROR-γ的二氢吡咯并吡啶抑制剂
-
Application No.: US15178796Application Date: 2016-06-10
-
Publication No.: US09481674B1Publication Date: 2016-11-01
- Inventor: David A. Claremon , Jing Yuan , Wei Zhao , Yajun Zheng
- Applicant: Vitae Pharmaceuticals, Inc.
- Applicant Address: US PA Fort Washington
- Assignee: Vitae Pharmaceuticals, Inc.
- Current Assignee: Vitae Pharmaceuticals, Inc.
- Current Assignee Address: US PA Fort Washington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Michael J. DeGrazia
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
Information query
